Neuroimmune and inflammatory processes have been locally associated with the amygdala in alcohol exposure and withdrawal. We and others have suggested that this inflammation in the amygdala may cause disturbance of neural function observed as anxiety and autonomic distress in withdrawal. Despite the potential importance of the robust neuroinflammatory response, the mechanisms contributing to this response are not well understood. We review literature that suggests the effects of alcohol, and other substances of abuse, cause dysbiosis of the gut microbiome. This peripheral response may modulate neuroprotective vagal afferent signaling that permits and exacerbates a neuroinflammatory response in the amygdala. We will examine the mounting evidence that suggests that (1) gut dysbiosis contributes to neuroinflammation, especially in the context of alcohol exposure and withdrawal, (2) the neuroinflammation in the amygdala involves the microglia and astrocytes and their effect on neural cells, and (3) amygdala neuroinflammation itself contributes directly to withdrawal behavior and symptoms. The contribution of the gut to an anxiogenic response is a promising therapeutic target for patients suffering with withdrawal symptoms given the safe and well-established methods of modulating the gut microbiome.
Introduction
The high prevalence of substance use disorders (SUDs), including alcoholism, motivates the need for increased understanding of physiological mechanisms accompanying addiction and withdrawal. Both addiction and withdrawal have pathologies and comorbidities that are associated with distinct changes in brain function and physiology. In previous work we found that the status of alcohol withdrawal produces a robust and sustained neuroinflammatory response in the central nucleus of the amygdala (CeA), a structure strongly associated with regulation of emotion (Freeman et al., 2012 (Freeman et al., , 2013 . We and others have suggested that the effects of inflammation on neuronal function drive some of the autonomic disturbances, anxiety, and other negative feelings associated with withdrawal (Retson et al., 2014). These neuroimmune processes appear to involve the activation of microglia and disturbances of the blood brain barrier. The source of this neuroinflammation is not yet understood, and our purpose in the present review is to consider the evidence that changes in the state of the gut microbiome may contribute to neuroimmune processes.
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